News 1 — Japanese

Medtronic will dominate Japanese DCB market over next five years, says GlobalData

DCB Market GlobalData Japanese Medtronic

Medtronic will dominate Japanese DCB market over next five years, says GlobalData

Medtronic will dominate Japanese DCB market over next five years, says GlobalData Following the full commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB), for the treatment of peripheral artery disease (PAD) in the upper leg - specifically, in the thigh (superficial femoral arteries (SFA)) and behind the knee (popliteal arteries), in Japan on 15 August 2018 by Dublin-based medical device company Medtronic, Sheryl Tang, Medical Device Analyst at leading data and analytics company GlobalData says: “IN.PACT Admiral DCB was first approved by Japan Pharmaceuticals and Medical Devices Agency (PMDA) in September 2017, shortly after the approval of CR Bard’s...

Read more →